| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/19/2004 | EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/19/2004 | EP0984965B1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors |
| 05/19/2004 | CN1498209A 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 05/19/2004 | CN1496981A Cycloamine derivative and its use as medicine |
| 05/19/2004 | CN1496740A Application of probuco monoester intreating amgiocardiopathy and inflammatry disease |
| 05/19/2004 | CN1496739A Application of probuco monoester in treating angiocardiopathy and inflammatory disease |
| 05/19/2004 | CN1496733A Cosmetic and/or skin applied of composition containing easy oxidation hydrophilic active component stablized by maleic anhydride copolymer |
| 05/19/2004 | CN1150195C Bicyclic nitrogen heterocycles |
| 05/19/2004 | CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors |
| 05/19/2004 | CN1150171C Bicyclic heterocycles, pharmaceutical compositions containing these compounds,and processes for preparing them |
| 05/19/2004 | CN1150035C Recombination plasmid and application in disease prevention and control |
| 05/19/2004 | CN1150005C External medicine for treating tinea |
| 05/19/2004 | CN1149983C Compositions and methos for treatment of anorectal disorders |
| 05/19/2004 | CN1149979C Medicinal composition |
| 05/19/2004 | CN1149971C Cosmetic or pharmaceutical compositions consisting of liposomes, its preparation method and use |
| 05/18/2004 | US6737507 Antiangiogenic peptides and compositions thereof |
| 05/18/2004 | US6737436 Pyrrole derivatives as phosphodiesterase VII inhibitors |
| 05/18/2004 | US6737246 Incubating substance with a mixture comprising a protein, marker substrate, which binds to the catalytic domain and is converted by the protein, and substrate; determining whether the marker substrate is converted by the protein |
| 05/18/2004 | US6737089 From the indian mulberry plant. |
| 05/18/2004 | US6737057 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| 05/18/2004 | US6737055 Isolated cathepsin L type cysteine proteases and reducing intercorneocyte cohesion/promoting desquamation therewith |
| 05/18/2004 | CA2301794C Improved enriched platelet wound healant |
| 05/18/2004 | CA2298645C Use of physiologically acceptable vanadium compounds, salts and complexes |
| 05/13/2004 | WO2004039978A2 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 05/13/2004 | WO2004039972A1 H17t213-transgenic animal, novel h17t213 protein and dna thereof |
| 05/13/2004 | WO2004039797A1 A special kind of indole compounds, their preparation, and their use in treatment and prevention of those disease such as cancer |
| 05/13/2004 | WO2004039794A1 Cell activator, process for producing cell activator and appratus therefor |
| 05/13/2004 | WO2004039454A1 Formulations containing melatonin, ginkgo biloba, and biotin |
| 05/13/2004 | WO2004039409A2 Composition comprising activators of ik potassium channels and calcineurin antagonists and use thereof |
| 05/13/2004 | WO2004039397A1 Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, in combination with alpha 1-antitrypsin polypeptides, or nucleic acids encoding them, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds |
| 05/13/2004 | WO2004039369A1 Daily melatonin dosing units |
| 05/13/2004 | WO2004039368A1 Peroral preparation for prevention of or treatment for atopic dermatitis |
| 05/13/2004 | WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers |
| 05/13/2004 | WO2004000293A3 Use of taurine or derivatives thereof for the treatment of alopecia |
| 05/13/2004 | WO2003099781A3 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 05/13/2004 | WO2003090684B1 Polymer compositions containing a macrocyclic triene compound |
| 05/13/2004 | WO2003079750A3 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |
| 05/13/2004 | WO2003037291A8 Cream for treatment of skin injured by the sun |
| 05/13/2004 | WO2002102804A8 New use of specific cyclolignans |
| 05/13/2004 | WO2002088348A3 Lipid producing cells and uses thereof |
| 05/13/2004 | US20040092745 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092598 Antiproliferative agnets; anticancer agents; skin disorders |
| 05/13/2004 | US20040092596 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders |
| 05/13/2004 | US20040092594 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 05/13/2004 | US20040092586 Oxidation resistance; aging resistance; skin disorders |
| 05/13/2004 | US20040092564 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/13/2004 | US20040092562 Methods for treating inflammatory conditions or inhibiting JNK |
| 05/13/2004 | US20040092551 Piperidine derivatives useful as CCR5 antagonists |
| 05/13/2004 | US20040092545 Sulfonamido ether substituted imidazoquinolines |
| 05/13/2004 | US20040092518 Compounds for the treatment of metabolic disorders |
| 05/13/2004 | US20040092516 Insulin resistance; antidiabetic agents; antilipemic agents; anticholesterol agents; cardiovascular disorders |
| 05/13/2004 | US20040092515 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors |
| 05/13/2004 | US20040092506 Administering estrogen antagonist; skin disorders; wrinkle resistance; antiarthritic agents; anticancer agents; wound healing agents |
| 05/13/2004 | US20040092454 3-biphenyl-4-yl-3-(2-(4-(pyridin-2-ylamino)pentanoylamino)-pen tanoyl amino)propionic acid derivatives |
| 05/13/2004 | US20040092429 Cardiovascular disorders; antiarrhythmia agents; controlling phosphorylation of cells, tissues |
| 05/13/2004 | US20040091912 Diagnostic method |
| 05/13/2004 | US20040091539 A topical composition in the form of a solid stick comprising a corticosteroid, petrolatum, a wax, propylene glycol, and an emulsifier; an outer protective covering being constructed to prevent hand contact; anhydrous; skin disorders |
| 05/13/2004 | US20040091501 Immunosuppresor agent derived from morbillivirus |
| 05/13/2004 | US20040091493 Active ingredient such as specified plant extract(s) or calcium compound that does not cause any inflammatory, irritation or intolerance reactions; tissue models for drug screening for drugs against skin disorders; dandruff, acne |
| 05/13/2004 | US20040091468 Novel transcriptional mediators of blood vessel development and endothelial differentiation |
| 05/13/2004 | US20040091443 Conditioning polymer encapsulated in lipid vesicle |
| 05/13/2004 | US20040091433 Chromene derivative |
| 05/13/2004 | DE10250870A1 Zusammensetzung enthaltend Aktivatoren von IK-Kaliumkanälen und Calcineurin-Antagonisten und deren Verwendung Composition containing activators of IK potassium channels and calcineurin antagonists and their use |
| 05/13/2004 | CA2504361A1 Formulations containing melatonin, ginkgo biloba, and biotin |
| 05/13/2004 | CA2504341A1 Melatonin daily dosing units |
| 05/13/2004 | CA2503634A1 Alpha 1-antichymotrypsin in combination with alpha 1-antitrypsin for the treatment of wounds |
| 05/12/2004 | EP1418293A1 System for the construction of water retaining walls, such as swimming pool walls, with prefabricated panels |
| 05/12/2004 | EP1418177A1 Novel pseudolaric acid-b derivatives, their preparation and pharmaceutical compositions |
| 05/12/2004 | EP1418164A1 New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists |
| 05/12/2004 | EP1417955A1 Humectant and cosmetics and external preparations containing the same |
| 05/12/2004 | EP1417328A2 Invasion complex and methods of targeting |
| 05/12/2004 | EP1417304A2 Method and composition for inhibiting heparanase activity |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417220A2 Irreversible cysteine protease inhibitors of legumain |
| 05/12/2004 | EP1417205A1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 05/12/2004 | EP1417191A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417181A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 05/12/2004 | EP1417173A1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 05/12/2004 | EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c |
| 05/12/2004 | EP1416954A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 05/12/2004 | EP1416948A1 Compositions for removal of toxins |
| 05/12/2004 | EP1416941A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 05/12/2004 | EP1416940A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 05/12/2004 | EP1416933A1 Substituted piperidines as modulators of the melanocortin receptor |
| 05/12/2004 | EP1416923A1 Reduction of hair growth |
| 05/12/2004 | EP1416916A1 Chitin microparticles and their medical uses |
| 05/12/2004 | EP1416912A2 Cosmetic and dermatological light protective formulations containing benzotriazole derivatives and latex particles |
| 05/12/2004 | EP1416907A1 Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 05/12/2004 | EP1416799A1 Methods and compositions for treating fungal infections |
| 05/12/2004 | EP1383464A4 Nail compositions and methods of administering same |
| 05/12/2004 | EP1339378A4 Use of cyclosporin a 7-thioamide derivatives for hair growth |
| 05/12/2004 | EP1309352B1 Antifungal ketoconazole composition for topical use |
| 05/12/2004 | EP1303284A4 Compositions and methods for the treatment of skin damage |
| 05/12/2004 | EP1200432B1 Amido spiropiperidines promote the release of growth hormone |
| 05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
| 05/12/2004 | EP1161410B1 Retinoid antagonists and use thereof |
| 05/12/2004 | EP1140835B1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 05/12/2004 | EP1114037B1 Benzoxazine and benzothiazine derivatives and their use in medicines |